Results 241 to 250 of about 673,928 (344)
Exosomes can reduce tissue damage in temporomandibular joint osteoarthritis (TMJOA), but rapid clearance limits their efficacy. This study encapsulates exosomes in hyaluronic acid hydrogels for controlled release. In a rat model, hydrogel‐encapsulated exosomes outperform free exosomes in preserving bone integrity and reducing tissue destruction ...
Victor Diez‐Guardia+7 more
wiley +1 more source
A patient with periumbilical hyperpigmentation and keratotic papules. [PDF]
Hedden M, Dugan K, Smith EH, Aria AB.
europepmc +1 more source
Fouilles effectuées au « Château des Cars », commune de Saint-Merd-les-Oussines (Corrèze)
Lucien Prieur, Franck Delage
openalex +2 more sources
Most in vitro cancer models lack cellular diversity, functional complexity, and clinical relevance. This work highlights the generation of an innovative dynamic tetraculture with autologous patient‐derived cells within a vascularized tumor‐on‐chip, as well as the recapitulation of endothelial anergy features induced by the tumor microenvironment ...
Christine Lansche+16 more
wiley +1 more source
Impact on the prognosis with the creation of a dedicated stroke to mesenteric ischaemia. [PDF]
Rudondy V+11 more
europepmc +1 more source
Glepaglutide (GL), a GLP‐2 analog with an extended half‐life (50 h), is currently undergoing clinical trials for patients with short bowel syndrome. GL requires subcutaneous injection, which poses challenges for potential patient compliance. To address this challenge, we loaded GL into a rectal foam formulation using CO2 as a permeation enhancer to ...
Wunan Zhang+9 more
wiley +1 more source
Modeling mesenchymal stromal cell support to hematopoiesis within a novel 3D artificial marrow organoid system. [PDF]
Schell B+13 more
europepmc +1 more source
This study presents a novel implantable drug delivery systemwith a biodegradable poly(caprolactone) membrane and compressed drug core forsustained release. These implantable devices deliver risperidone in vitro for 170 days and in vivo for 49 days in rats, showing promise for chronic conditions like schizophrenia.
Linlin Li+9 more
wiley +1 more source
Improving human papillomavirus vaccination coverage in France: a need to act but not to rush. [PDF]
Thilly N+9 more
europepmc +1 more source